Gloved hand holding translucent pharmaceutical capsule refracting iridescent light against deep black background
Pharma Email Engineering

YOUR EMAILS
SHOULD WORK
AS HARD AS YOUR MOLECULES.

MLR-compliant email sequences engineered for HCP adoption.
From inbox zero to formulary — without a single compliance flag.

94%
MLR first-pass rate
3.2×
HCP open rate vs industry
47
Specialty launches engineered
0
HIPAA incidents. Ever.
01
Chapter 01 — The Problem

PRE-LAUNCH
CHAOS
LOOKS LIKE THIS.

Three agencies. Seven MLR rounds. Eleven months to first send. Meanwhile, your competitors own the formulary.

Avg MLR rounds before approval6.8×
Emails killed for ISI violations34%
Days lost to revision cycles127
MLR Review Queue — 23 items
RE: VELTREX Launch Sequence — Draft 4
mlr-review@agency.co
REJECTED
HCP Segment: Oncologists — Q1 Nurture
campaigns@mediagency.com
REJECTED
Subject Line Compliance Check Needed
regulatory@pharma.com
PENDING
URGENT: 3 emails flagged for ISI violations
mlr@legalteam.com
REJECTED
Formulary Update Email — Rev 7 (Final?)
medical-affairs@brand.com
REJECTED
+ 18 more awaiting review
⚠ Average pharma email takes 4.3 months from brief to deployment. Your HCPs have already chosen a competitor.
02
Chapter 02 — The System

ORDER
IMPOSED.
COMPLIANCE
THREADED.

Our workflow maps to your MLR calendar from day one. Every email exits review in a single round — or we rebuild it free.

The Prescribe Guarantee
First-pass MLR approval or we revise at no cost. Guaranteed in every engagement.

Compliance Architecture

APPROVED

ISI-first templating with regulatory guardrails baked into every module.

Day 1–3

HCP Segmentation Engine

APPROVED

Specialty-specific targeting: oncologists, immunologists, rare disease specialists.

Day 4–7

MLR-Ready Content System

APPROVED

Claims library pre-approved by medical. Subject lines with compliance metadata.

Day 8–14

Sequence Deployment

LIVE

Trigger-based nurture flows synced to formulary milestones and P&T calendars.

Day 15–21
Total: First Send21 Days
03
Chapter 03 — Deployment

INBOX.
RENDERED.
DELIVERED.

Veeva-integrated. ESP-agnostic. Rendering across every client HCPs actually use — from Outlook 2016 to iOS Mail.

Integrated Platforms
Veeva VaultSalesforce MCMarketoHubSpotExactTargetEloqua
HIPAA-compliant data handling on all deployments. No PHI in email payloads. Ever.
Desktop — Veeva Vault● Delivered
Dr. Sarah Chen, Medical Science Liaison9:14 AM
VELTREX® (veltrexinib): New PFS data in 1L NSCLC
Important safety information is included below. For HCPs only.
847 opens
Mobile — Outlook● Opened
Prescribe for Novapharm11:02 AM
Q4 Formulary Update: VELTREX® on Tier 2
Your patients now have access. See coverage details →
2,341 opens
Rendering live across 47 email clients · 0 compliance flags detected
04
Chapter 04 — Outcomes

THE DATA
DOESN'T
LIE.

Across 47 specialty drug launches. Oncology, immunology, rare disease, CNS. The pattern holds.

"Prescribe got our VELTREX launch emails through MLR in a single round. First time in my 12 years in pharma that's happened."

KR
Kathryn Reeves
VP Commercial Operations, Novapharm

"The HCP segmentation alone was worth the engagement. Open rates we hadn't seen since before GDPR."

MO
Marcus Okonkwo
Director, Medical Affairs, Stellaris Bio
HCP Open Rate
vs 11.2% pharma avg
12%38%
+216%
Script Lift (90-day)
Oncology specialty segment
Baseline+31%
+31%
MLR First-Pass Rate
Down from 6.8 avg rounds
41%94%
+129%
Time to First Send
From brief to deployment
127 days21 days
−83%
47
Launches
$2.1B
Revenue influenced
0
HIPAA incidents
05
Ready to fix your MLR bottleneck?
Compliance-Ready Audit

Tell us where
your MLR breaks.

We'll audit your current email program and return a compliance gap report within 5 business days. No pitch. Just data.

No Gmail. No Yahoo. Pharma professionals only. We respond within 2 business days.